viernes, 30 de marzo de 2018

Lisfranc Injury Is Not Always Career-Ending Now - Ivanhoe Broadcast News, Inc.

Lisfranc Injury Is Not Always Career-Ending Now - Ivanhoe Broadcast News, Inc.


TAMPA, Fla. (Ivanhoe Newswire) — There are more than three million cases a year in the US of enlarged prostate, also known as BPH. The condition is very common in men over 60, and among other things, causes difficulty with urination and creates a feeling of urgency. But now doctors are turning to nature for treatment.

PITTSBURGH, Pa. (Ivanhoe Newswire) — A Lisfranc injury or fracture is named after the French doctor who first described it in the 1800’s. These days, Lisfranc is more common among athletes who are up on their toes like soccer players, gymnasts, and dancers. Orthopedic specialists are working to keep athletes in the game.

CLEVELAND, Ohio. (Ivanhoe Newswire) — A heart valve replacement involves swapping a damaged valve with an artificial one. There are two kinds of artificial valves and until now, younger patients were only able to get one type. But a new, state-of-the art valve is changing the game.

NEW YORK, N.Y. (Ivanhoe Newswire) — Thirty percent of all Americans will be affected by peripheral neuropathy, a condition that impacts nerves leading to the arms and legs. In many cases, doctors prescribe medicines to help manage the pain, burning and tingling. Now, researchers are testing a new non-addictive treatment inspired from a surprising source.

BIRMINGHAM, Ala. (Ivanhoe Newswire) — Fibroids are non-cancerous, but can cause excessive pain and heaviness in the pelvis, frequent urination and heavy bleeding during periods. Many women have been told that a hysterectomy is their only permanent treatment option, which usually takes about six weeks for a full recovery. But a minimally-invasive procedure can offer women a quicker recovery.


Quote of the week:

“Prejudice is a great time saver. You can form opinions without having to get the facts.” 

— E.B. White

Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!

Website Information:

Content Licensing:

No hay comentarios:

Publicar un comentario